Login to Your Account

Other News To Note

Tuesday, October 22, 2013
Anacor Pharmaceuticals Inc., of Palo Alto, Calif., signed a research agreement with the U.S. Department of Defense, Defense Threat Reduction Agency for design of new classes of systemic antibiotics.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription